Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

被引：6

作者：

Yi, Jun Ho ^{[1
]}

Kim, Seok Jin ^{[2
]}

Yoon, Dok Hyun ^{[3
]}

Suh, Cheolwon ^{[3
]}

Chang, Myung Hee ^{[4
]}

Yang, Deok Hwan ^{[5
]}

Jo, Jae-Cheol ^{[6
]}

Hyun, Shin Young ^{[7
]}

Eom, Hyeon-Seok ^{[8
]}

Lee, Jeong-Ok ^{[9
]}

Kwon, Ji Hyun ^{[10
]}

Han, Sang Hoon ^{[11
]}

Lee, Seung-Shin ^{[12
]}

Kwak, Jae-Yong ^{[13
]}

Kim, Se Hyung ^{[14
]}

Kim, Dae Sik ^{[15
]}

Lee, Ji Hyun ^{[16
]}

Oh, Sung Yong ^{[16
]}

Ryoo, Hun Mo ^{[17
]}

Kim, Hyo Jung ^{[18
]}

Kim, Won Seog ^{[2
]}

机构：

[1] Chung Ang Univ, Div Hematol Oncol, Dept Med, Seoul 06973, South Korea

[2] Sungkyunkwan Univ, Div Hematol & Oncol, Dept Med, Samsung Med Ctr,Sch Med, 50 Irwon Dong, Seoul 06351, South Korea

[3] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea

[4] Natl Hlth Insurance Corp Ilsan Hosp, Goyang 10444, South Korea

[5] Chonnam Natl Univ, Sch Med, Dept Hematooncol, Hwasun Hosp, Hwasun 58128, Gwangju, South Korea

[6] Univ Ulsan, Dept Hematol & Oncol, Ulsan Univ Hosp, Coll Med, Ulsan 44033, South Korea

[7] Yonsei Univ, Dept Internal Med, Coll Med, Wonju 26426, South Korea

[8] Natl Canc Ctr, Dept Internal Med, Gyeonggi Do 10408, Goyang, South Korea

[9] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam 13620, South Korea

[10] ChungBuk Natl Univ Hosp, Dept Internal Med, Chungbuk 28644, Cheongju, South Korea

[11] Jeju Natl Univ, Dept Internal Med, Jeju Natl Univ Hosp, Sch Med, Jeju 63241, South Korea

[12] Wonkwang Univ Hosp, Dept Hematol Oncol, Iksan 54538, South Korea

[13] Jeonbuk Natl Univ, Dept Internal Med, Sch Med, Jeonju 54907, South Korea

[14] Soonchunhyang Univ, Div Hematol Oncol, Dept Internal Med, Coll Med,Bucheon Hosp, Bucheon 14584, South Korea

[15] Korea Univ, Div Hematol Oncol, Dept Internal Med, Guro Hosp, Seoul 08308, South Korea

[16] Dong A Univ, Div Hematol Oncol, Dept Internal Med, Coll Med, Busan 49201, South Korea

[17] Catholic Univ Daegu, Dept Internal Med, Div Hematol Oncol, Daegu 42472, South Korea

[18] Hallym Univ, Div Hematol Oncol, Dept Internal Med, Sacred Heart Hosp,Coll Med, Anyang 14068, South Korea

来源：

CANCER COMMUNICATIONS | 2021年 / 41卷 / 03期

关键词：

D O I：

10.1002/cac2.12150

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：275 / 278

页数：4

共 50 条

[31] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
Maruyama, Dai
Nagai, Hirokazu
Fukuhara, Noriko
Kitano, Toshiyuki
Ishikawa, Takayuki
Shibayama, Hirohiko
Choi, Ilseung
Hatake, Kiyohiko
Uchida, Toshiki
Nishikori, Momoko
Kinoshita, Tomohiro
Matsuno, Yoshihiro
Nishikawa, Tomoaki
Takahara, Satoko
Tobinai, Kensei
CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
[32] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Mantle Cell Lymphoma in China: A Retrospective Analysis Using a Real-World Database
Liu, Yin
Chen, Yanfei
Huang, Ruijian
Xiao, Yue
Jiang, Feng
Yi, Shuhua
Zhou, Jifang
BLOOD, 2023, 142
[33] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
Paillassa, Jerome
HEMATOLOGIE, 2015, 21 (05): : 257 - 259
[34] Real-world healthcare resource utilization and costs among relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients receiving ibrutinib or chemoimmunotherapy (CIT).
Ghosh, Nilanjan
Emond, Bruno
Lafeuille, Marie-Helene
Cote-Sergent, Aurelie
Lefebvre, Patrick
Huang, Qing
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[35] Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Yuankai Shi
Bo Jia
Wei Xu
Wenyu Li
Ting Liu
Peng Liu
Weili Zhao
Huilai Zhang
Xiuhua Sun
Haiyan Yang
Xi Zhang
Jie Jin
Zhengming Jin
Zhiming Li
Lugui Qiu
Mei Dong
Xiaobing Huang
Yi Luo
Xiaodong Wang
Xin Wang
Jianqiu Wu
Jingyan Xu
Pingyong Yi
Jianfeng Zhou
Hongming He
Lin Liu
Jianzhen Shen
Xiaoqiong Tang
Jinghua Wang
Jianmin Yang
Qingshu Zeng
Zhihui Zhang
Zhen Cai
Xiequn Chen
Kaiyang Ding
Ming Hou
Huiqiang Huang
Xiaoling Li
Rong Liang
Qifa Liu
Yuqin Song
Hang Su
Yuhuan Gao
Lihong Liu
Jianmin Luo
Liping Su
Zimin Sun
Huo Tan
Huaqing Wang
Jingwen Wang
Journal of Hematology & Oncology, 10
[36] Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Shi, Yuankai
Jia, Bo
Xu, Wei
Li, Wenyu
Liu, Ting
Liu, Peng
Zhao, Weili
Zhang, Huilai
Sun, Xiuhua
Yang, Haiyan
Zhang, Xi
Jin, Jie
Jin, Zhengming
Li, Zhiming
Qiu, Lugui
Dong, Mei
Huang, Xiaobing
Luo, Yi
Wang, Xiaodong
Wang, Xin
Wu, Jianqiu
Xu, Jingyan
Yi, Pingyong
Zhou, Jianfeng
He, Hongming
Liu, Lin
Shen, Jianzhen
Tang, Xiaoqiong
Wang, Jinghua
Yang, Jianmin
Zeng, Qingshu
Zhang, Zhihui
Cai, Zhen
Chen, Xiequn
Ding, Kaiyang
Hou, Ming
Huang, Huiqiang
Li, Xiaoling
Liang, Rong
Liu, Qifa
Song, Yuqin
Su, Hang
Gao, Yuhuan
Liu, Lihong
Luo, Jianmin
Su, Liping
Sun, Zimin
Tan, Huo
Wang, Huaqing
Wang, Jingwen
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
[37] Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
Sawalha, Yazeed
Sarosiek, Shayna R.
Welkie, Rina Li
Seif, Sherif
Thapa, Shrinjaya
Zanwar, Saurabh
Cahill, Kirk
Treitman, Rachel
Shah, Haikoo
Arora, Shagun
Pongas, Georgios
Winter, Allison
Major, Ajay
Riedell, Peter A.
Palomba, Maria Lia
Kapoor, Prashant
Grajales-Cruz, Ariel F.
Shain, Kenneth H.
Thomas, Sheeba K.
Castillo, Jorge J.
BLOOD, 2023, 142
[38] Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
Maruyama, Dai
Nagai, Hirokazu
Fukuhara, Noriko
Kitano, Toshiyuki
Ishikawa, Takayuki
Nishikawa, Tomoaki
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2019, 59 (02) : 98 - 100
[39] A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma
Martin, Peter
Goy, Andre
Ramchandren, Radhakrishnan
Ferrante, Lucille
Londhe, Anil
McGowan, Tracy
Bartlett, Nancy L.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 1027 - 1030
[40] Ibrutinib at first relapse for mantle cell lymphoma: a United Kingdom real world analysis of outcomes in 185 Patients
McCulloch, R.
Rule, S.
Eyre, T.
Bolam, S.
Creasey, T.
Dutton, D.
Dawi, S.
Wilson, M.
Miles, O.
Harrison, S.
Goradia, H.
McMillan, A.
McIlroy, G.
Robinson, A.
Mowete, C.
Furtado, M.
Tucker, D.
Attwell, L.
Maddox, J.
Shenouda, A.
Shah, N.
Bond, A.
Kelsey, P.
Abdulgawad, A.
Clay, J.
Langridge, A.
Turner, D.
Parry, H.
Buka, R.
Pryce, A.
Arasaretnam, A.
Willan, J.
Willoughby, S.
Walker, R.
Campbell, G.
Phillips, N.
McCarthy, H.
Johnston, R.
Lambert, J.
Osborne, W.
Mckay, P.
Lewis, D.
Bishton, M.
Crosbie, N.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 104 - 105

← 1 2 3 4 5 →